Jeffrey Skinner
Net worth: 175 269 $ as of 2024-03-30
Profile
Jeffrey Skinner worked as the Director of Business Development at SteriMax, Inc. from 2012 to 2014.
He then worked as the Vice President of Business Development at ChitogenX, Inc. After that, he worked as the Vice President of Business Development at Valeo Pharma, Inc. from 2014 to 2023.
Mr. Skinner received his undergraduate degree and MBA from the University of Western Ontario in 1997 and 1999, respectively.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VALEO PHARMA INC CLASS A
1.42% | 2023-03-14 | 1,402,150 ( 1.42% ) | 175 269 $ | 2024-03-30 |
Former positions of Jeffrey Skinner
| Companies | Position | End |
|---|---|---|
| VALEO PHARMA INC. | Corporate Officer/Principal | 2023-06-30 |
SteriMax, Inc.
 SteriMax, Inc. Pharmaceuticals: MajorHealth Technology SteriMax, Inc. provides pharmaceutical products and services. The firm specializes in the development, production, marketing and distribution of essential hospital and retail pharmacy products to the Canadian healthcare market. Its products include BaciJect, Bupivacaine Injection BP, ceFAZolin for Injection, and AcetaZOLAMIDE for Injection USP. The company was founded by Mahen J. Acharya and is headquartered in Oakville, Canada. | Corporate Officer/Principal | 2014-06-30 |
| CHITOGENX INC. | Corporate Officer/Principal | - |
Training of Jeffrey Skinner
| University of Western Ontario | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CHITOGENX INC. | Health Technology |
| VALEO PHARMA INC. | Health Technology |
| Private companies | 1 |
|---|---|
SteriMax, Inc.
SteriMax, Inc. Pharmaceuticals: MajorHealth Technology SteriMax, Inc. provides pharmaceutical products and services. The firm specializes in the development, production, marketing and distribution of essential hospital and retail pharmacy products to the Canadian healthcare market. Its products include BaciJect, Bupivacaine Injection BP, ceFAZolin for Injection, and AcetaZOLAMIDE for Injection USP. The company was founded by Mahen J. Acharya and is headquartered in Oakville, Canada. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Skinner
